IWC

iShares Micro-Cap ETF

Citron recommended that investors should own three Churchill Corp shares for every single Rigetti stock they own.

The stock experienced an 80% increase in user message count over the last 24 hours, as of Monday morning, on Stocktwits.

The company stated that its investigational drug alone did not cause weight loss compared to the placebo in a mid-stage trial.

FDA’s Fast Track designation is designed to facilitate the development and expedite the review of drugs intended to treat serious conditions and fill an unmet medical need.

The company’s transformation plan aims to achieve revenue growth starting in the fourth quarter through strategic acquisitions and international alliances, while also managing increased organizational complexity.

The agreement enables the critical battery materials company to broaden its services beyond commercial clients to include direct consumer participation in recycling efforts.

The stock nearly doubled in value between September 18 and September 24, following a strong earnings report.

Fractyl Health expects to file with the U.S. Food and Drug Administration for the approval of Revita in the second half of 2026.

Wedbush raised its price target on PepGen to $9 from $7 and kept an ‘Outperform’ rating on the shares, while H.C. Wainwright hiked its price target on the stock to $12 from $8.